NCT01634464 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Campoy C, Martín-Bautista E, García-Valdés L, Florido J, Agil A, Lorente JA, Marcos A, López-Sabater MC, Miranda-León T, Sanz Y, Molina-Font JA; grupo PREOBE
[Study of maternal nutrition and genetic on the foetal adiposity programming (The PREOBE study)]
Santacruz A, Collado MC, García-Valdés L, Segura MT, Martín-Lagos JA, Anjos T, Martí-Romero M, Lopez RM, Florido J, Campoy C, Sanz Y
Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J

The Role of Nutrition and Maternal Genetics on the Programming of Development of Fetal Adipose Tissue. Search for Markers of the Obesity Risk in Early Stages of Life

Details for clinical trial NCT01634464

Clinical trial NCT01634464 - References